Rapamycin extends murine lifespan but has limited effects on aging
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Aging is a major risk factor for a large number of disorders and functional impairments. Therapeutic targeting of the aging process may therefore represent an innovative strategy in the quest for novel and broadly effective treatments against age-related diseases. The recent report of lifespan extension in mice treated with the FDA-approved mTOR inhibitor rapamycin represented the first demonstration of pharmacological extension of maximal lifespan in mammals. Longevity effects of rapamycin may, however, be due to rapamycin's effects on specific life-limiting pathologies, such as cancers, and it remains unclear if this compound actually slows the rate of aging in mammals. Here, we present results from a comprehensive, large-scale assessment of a wide range of structural and functional aging phenotypes, which we performed to determine whether rapamycin slows the rate of aging in male C57BL/6J mice. While rapamycin did extend lifespan, it ameliorated few studied aging phenotypes. A subset of aging traits appeared to be rescued by rapamycin. Rapamycin, however, had similar effects on many of these traits in young animals, indicating that these effects were not due to a modulation of aging, but rather related to aging-independent drug effects. Therefore, our data largely dissociate rapamycin's longevity effects from effects on aging itself.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“some SASP inhibitors can have agent-specific off-target effects, for example, rapamycin, which can cause nephrotoxicity, metabolic impairment and susceptibility to infections, at least at higher doses in mice109.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [109]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Rapamycin and its analogs (so-called ‘rapalogs’) suppress the SASP by inhibiting mTOR and appear to extend healthspan and lifespan in mice105,108,109.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [109]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A study by Neff and colleagues found that rapamycin significantly reduced the proportion of 16 month old mice with cancer and/or precancerous lesions 87, and suggested that this indicated that the effects of rapamycin on lifespan was driven by its anti-cancer effects.”
From Targeting the biology of aging with mTOR inhibitors (2023) · cites this paper as [87]
In the citing paper
“Studies have provided evidence that rapamycin only prolongs lifespan through antitumor mechanisms, thereby inhibiting the main pathological changes in mice [190, 191].”
From Immunosenescence: a key player in cancer development (2020) · cites this paper as [190]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sahn, D. J., DeMaria, A., Kisslo, J., & Weyman, A. (1978) · Circulation · doi:10.1161/01.cir.58.6.1072 · Cited by 7,430
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766 · cited 10×
“Rapamycin treatment was essentially as previously described (9).”
InfluentialRegulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway
Kapahi, P., Zid, B. M., Harper, T., Koslover, D., Sapin, V., & Benzer, S. (2004) · Current Biology · doi:10.1016/j.cub.2004.03.059 · Cited by 1,293
Regulation of Yeast Replicative Life Span by TOR and Sch9 in Response to Nutrients
Kaeberlein, M., Powers, R. W., Steffen, K. K., Westman, E. A., Hu, D., Dang, N., Kerr, E. O., Kirkland, K. T., Fields, S., & Kennedy, B. K. (2005) · Science · doi:10.1126/science.1115535 · Cited by 1,293
Experience-Induced Neurogenesis in the Senescent Dentate Gyrus
Kempermann, G., Kuhn, H. G., & Gage, F. H. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03206.1998 · Cited by 1,150 · cited 1×
“There is a known strong age-dependent decline in adult hippocampal neurogenesis (21).”
Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span
Selman, C., Tullet, J. M. A., Wieser, D., Irvine, E., Lingard, S. J., Choudhury, A. I., Claret, M., Al-Qassab, H., Carmignac, D., Ramadani, F., et al. (2009) · Science · doi:10.1126/science.1177221 · Cited by 1,120
Influence of TOR kinase on lifespan in C. elegans
Vellai, T., Takacs-Vellai, K., Zhang, Y., Kovacs, A. L., Orosz, L., & Müller, F. (2003) · Nature · doi:10.1038/426620a · Cited by 1,057
Extension of Chronological Life Span in Yeast by Decreased TOR Pathway Signaling
Powers, R. W., Kaeberlein, M., Caldwell, S. D., Kennedy, B. K., & Fields, S. (2006) · Genes & Development · doi:10.1101/gad.1381406 · Cited by 982
Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice
Miller, R. A., Harrison, D. E., Astle, C. M., Baur, J. A., Boyd, A. R., de Cabo, R., Fernandez, E., Flurkey, K., Javors, M. A., Nelson, J. F., et al. (2011) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glq178 · Cited by 896
CellProfiler™: Free, Versatile Software for Automated Biological Image Analysis
Lamprecht, M. R., Sabatini, D. M., & Carpenter, A. E. (2007) · BioTechniques · doi:10.2144/000112257 · Cited by 895
Research works printed but not linked: 4
- Olshansky, 2006, Scientist., 20, 28
- Frith, 1980, Lab Anim Sci., 30, 835
- Coquelin, 1982, Am J Physiol., 243, E257
- Sommer C, Straehle C, Köthe U, Hamprecht FA. 8th IEEE International Symposium on Biomedical Imaging. March 30-April 2, 2011; Chicago, Illinois, USA.
Cited by
Items 101–200 of 371
Evaluation of off-label rapamycin use to promote healthspan in 333 adults
Kaeberlein, T. L., Green, A. S., Haddad, G., Hudson, J., Isman, A., Nyquist, A., Rosen, B. S., Suh, Y., Zalzala, S., Zhang, X., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00818-1 · Cited by 70
Novel strategies for anti-aging drug discovery
Saraswat, K., & Rizvi, S. I. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1349750 · Cited by 66
“and female C57BL/6J mice [60,61], male C57BL/6J Rj mice [62], female 129/Sv mice [63], and female FVB/N HER-2/neu mice”
MethodV-ATPase/mTOR Signaling Regulates Megalin-Mediated Apical Endocytosis
Gleixner, E. M., Canaud, G., Hermle, T. F., Guida, M. C., Kretz, O., Helmstädter, M., Huber, T. B., Eimer, S., Terzi, F., & Simons, M. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.035 · Cited by 66
Translational geroscience: A new paradigm for 21st century medicine
Kaeberlein, M. (2017) · Translational Medicine of Aging · doi:10.1016/j.tma.2017.09.004 · Cited by 65
Rapamycin Increases Mortality in db/db Mice, a Mouse Model of Type 2 Diabetes
Sataranatarajan, K., Ikeno, Y., Bokov, A., Feliers, D., Yalamanchili, H., Lee, H. J., Mariappan, M. M., Tabatabai-Mir, H., Diaz, V., Prasad, S., et al. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv170 · Cited by 65
Aging Research—Where Do We Stand and Where Are We Going?
Guarente, L. (2014) · Cell · doi:10.1016/j.cell.2014.08.041 · Cited by 73
Fan, S., Lin, C., Wei, Y., Yeh, S., Tsai, Y., Lee, A. C., Lin, W., & Wang, P. (2021) · Aging Cell · doi:10.1111/acel.13510 · Cited by 63
Autophagy as a Therapeutic Target to Enhance Aged Muscle Regeneration
Lee, D. E., Bareja, A., Bartlett, D. B., & White, J. P. (2019) · Cells · doi:10.3390/cells8020183 · Cited by 64
Marín‐Aguilar, F., Castejón‐Vega, B., Alcocer‐Gómez, E., Lendines‐Cordero, D., Cooper, M. A., de la Cruz‐Ojeda, P., Andújar, E., Pérez-Alegre, M., Muntané, J., Pérez‐Pulido, A. J., et al. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz239 · Cited by 66
Jeong, J.-J., Woo, J.-Y., Kim, K.-A., Han, M. J., & Kim, D.-H. (2015) · Letters in Applied Microbiology · doi:10.1111/lam.12393 · Cited by 63
Honda, Y., Araki, Y., Hata, T., Ichihara, K., Ito, M., Tanaka, M., & Honda, S. (2015) · Journal of Aging Research · doi:10.1155/2015/425261 · Cited by 73
de Cavanagh, E. M. V., Inserra, F., & Ferder, L. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00459.2014 · Cited by 70
Rapamycin, proliferation and geroconversion to senescence
Blagosklonny, M. V. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1554781 · Cited by 62
Fok, W. C., Bokov, A., Gelfond, J., Yu, Z., Zhang, Y., Doderer, M., Chen, Y., Javors, M., Wood, W. H., Zhang, Y., et al. (2014) · Aging Cell · doi:10.1111/acel.12175 · Cited by 62
Chung, E. J., Sowers, A. L., Thetford, A., McKay-Corkum, G. B., Chung, S. I., Mitchell, J. B., & Citrin, D. E. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.07.026 · Cited by 63
Cause-of-Death Analysis in Rodent Aging Studies
Snyder, J. M., Ward, J. M., & Treuting, P. M. (2015) · Veterinary Pathology · doi:10.1177/0300985815610391 · Cited by 62
The role of the ribosome in the regulation of longevity and lifespan extension
MacInnes, A. W. (2016) · WIREs RNA · doi:10.1002/wrna.1325 · Cited by 61
Rapamycin Reverses Metabolic Deficits in Lamin A/C-Deficient Mice
Liao, C.-Y., Anderson, S. S., Chicoine, N. H., Mayfield, J. R., Academia, E. C., Wilson, J. A., Pongkietisak, C., Thompson, M. A., Lagmay, E. P., Miller, D. M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.040 · Cited by 61
mTOR inhibition acts as an unexpected checkpoint in p53-mediated tumor suppression
Kon, N., Ou, Y., Wang, S.-J., Li, H., Rustgi, A. K., & Gu, W. (2021) · Genes & Development · doi:10.1101/gad.340919.120 · Cited by 61
Zumbrennen-Bullough, K. B., Becker, L., Garrett, L., Hölter, S. M., Calzada-Wack, J., Mossbrugger, I., Quintanilla-Fend, L., Racz, I., Rathkolb, B., Klopstock, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098072 · Cited by 60
Self-citationWilson, K. A., Beck, J. N., Nelson, C. S., Hilsabeck, T. A. U., Promislow, D., Brem, R. B., & Kapahi, P. (2020) · Current Biology · doi:10.1016/j.cub.2020.05.020 · Cited by 70
Yin, J., Liu, X., Yuan, J., Jiang, J. S., & Cai, S. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4013-13.2014 · Cited by 62
Liao, C., & Kennedy, B. K. (2014) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-397920-9.00003-2 · Cited by 62
Energetic interventions for healthspan and resiliency with aging
Huffman, D. M., Schafer, M. J., & LeBrasseur, N. K. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.05.012 · Cited by 54
Preparing for an Aging World: Engaging Biogerontologists, Geriatricians, and the Society
Nikolich-Žugich, J., Goldman, D. P., Cohen, P. R., Cortese, D., Fontana, L., Kennedy, B. K., Mohler, M. J., Olshansky, S. J., Perls, T., Perry, D., et al. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv164 · Cited by 54
Disease or not, aging is easily treatable
Blagosklonny, M. V. (2018) · Aging · doi:10.18632/aging.101647 · Cited by 60
Evangelisti, C., Cenni, V., & Lattanzi, G. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12928 · Cited by 53
Jahrling, J., & Laberge, R.-M. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150610125856 · Cited by 53
Next Generation Strategies for Geroprotection via mTORC1 Inhibition
Dumas, S. N., & Lamming, D. W. (2020) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glz056 · Cited by 53
Briga, M., Jimeno, B., & Verhulst, S. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.01.030 · Cited by 54
Kaeberlein, M. (2016) · Veterinary Pathology · doi:10.1177/0300985815591082 · Cited by 52
mTOR Inhibition: From Aging to Autism and Beyond
Kaeberlein, M. (2013) · Scientifica · doi:10.1155/2013/849186 · Cited by 51
Tardif, S., Ross, C., Bergman, P., Fernandez, E., Javors, M., Salmon, A., Spross, J., Strong, R., & Richardson, A. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu101 · Cited by 51
Ryu, J. Y., Choi, H. M., Yang, H.-I., & Kim, K. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186887 · Cited by 55
Autophagy—A key pathway for cardiac health and longevity
Woodall, B. P., & Gustafsson, Å. B. (2018) · Acta Physiologica · doi:10.1111/apha.13074 · Cited by 52
Geroprotectors: A role in the treatment of frailty
Trendelenburg, A., Scheuren, A. C., Potter, P. K., Müller, R., & Bellantuono, I. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.03.002 · Cited by 54
Rapamycin and Ageing: When, for How Long, and How Much?
Kaeberlein, M. (2014) · Journal of Genetics and Genomics · doi:10.1016/j.jgg.2014.06.009 · Cited by 48
Barger, J. L., Vann, J. M., Cray, N. L., Pugh, T. D., Mastaloudis, A., Hester, S. N., Wood, S. M., Newton, M. A., Weindruch, R., & Prolla, T. A. (2017) · Aging Cell · doi:10.1111/acel.12608 · Cited by 48
Cell senescence in cardiometabolic diseases
Grootaert, M. O. J. (2024) · npj Aging · doi:10.1038/s41514-024-00170-4 · Cited by 61
M(o)TOR of pseudo-hypoxic state in aging: Rapamycin to the rescue
Leontieva, O. V., & Blagosklonny, M. V. (2014) · Cell Cycle · doi:10.4161/cc.27973 · Cited by 46
Manipulation of health span and function by dietary caloric restriction mimetics
Roth, G. S., & Ingram, D. K. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12834 · Cited by 46
Rapamycin Attenuates Age-associated Changes in Tibialis Anterior Tendon Viscoelastic Properties
Zaseck, L. W., Miller, R. A., & Brooks, S. V. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv307 · Cited by 46
Fasting and fasting-mimicking diets for chemotherapy augmentation
Brandhorst, S. (2021) · GeroScience · doi:10.1007/s11357-020-00317-7 · Cited by 57
Wang, Q., Wu, S., Zhu, H., Ding, Y., Dai, X., Ouyang, C., Han, Y.-M., Xie, Z., & Zou, M.-H. (2017) · Autophagy · doi:10.1080/15548627.2016.1263776 · Cited by 45
Deficiency in mTORC1‐controlled C/EBPβ‐mRNA translation improves metabolic health in mice
Zidek, L. M., Ackermann, T., Hartleben, G., Eichwald, S., Kortman, G., Kiehntopf, M., Leutz, A., Sonenberg, N., Wang, Z., von Maltzahn, J., et al. (2015) · EMBO Reports · doi:10.15252/embr.201439837 · Cited by 50
Rapamycin increases fetal hemoglobin and ameliorates the nociception phenotype in sickle cell mice
Khaibullina, A., Almeida, L. E. F., Wang, L., Kamimura, S., Wong, E. C. C., Nouraie, M. S., Marić, I., Albani, S. H., Finkel, J. C., & Quezado, Z. (2015) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2015.08.001 · Cited by 44
Luo, Y., Zhou, J., Li, M., Wu, P., Hu, Z., Ni, L., Jin, Y., Chen, J., & Wang, F. (2015) · Aging Cell · doi:10.1111/acel.12282 · Cited by 48
Dietary restriction and the pursuit of effective mimetics
Selman, C. (2014) · Proceedings of The Nutrition Society · doi:10.1017/s0029665113003832 · Cited by 53
Recent Progress in Metabolic Signaling Pathways Regulating Aging and Life Span
Newgard, C. B., & Pessin, J. E. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu058 · Cited by 43
The Geroscience Hypothesis: Is It Possible to Change the Rate of Aging?
Austad, S. N. (2016) · Advances in Geroscience · doi:10.1007/978-3-319-23246-1_1 · Cited by 43
Parkhitko, A. A., Favorova, O. O., Khabibullin, D., Anisimov, V. N., & Henske, E. P. (2014) · Biochemistry (Moscow) · doi:10.1134/s0006297914020023 · Cited by 48
Sharp, Z. D., & Strong, R. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112166 · Cited by 40
Unveiling the impact of aging on BBB and Alzheimer's disease: Factors and therapeutic implications
Nelson, V. K., Jha, N. K., Nuli, M. V., Gupta, S. K., Kanna, S., Gahtani, R. M., Hani, U., Singh, A. K., Abomughaid, M. M., Abomughayedh, A. M., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102224 · Cited by 48
Mitochondrial regulation of cardiac aging
Wang, Y., Li, Y., He, C., Gou, B., & Song, M. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.12.008 · Cited by 46
Xie, K., Fuchs, H., Scifo, E., Liu, D., Aziz, A., Aguilar-Pimentel, J. A., Amarie, O. V., Becker, L., da Silva-Buttkus, P., Calzada-Wack, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34515-y · Cited by 41
Self-citationBischof, E. Y., Siow, R. C. M., Zhavoronkov, A. A., & Kaeberlein, M. R. (2021) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(20)30068-4 · Cited by 41
Lifespan Modulation in Mice and the Confounding Effects of Genetic Background
Mulvey, L., Sinclair, A., & Selman, C. (2014) · Journal of Genetics and Genomics · doi:10.1016/j.jgg.2014.06.002 · Cited by 40
Aging and Systemic Lupus Erythematosus - Immunosenescence and Beyond
van den Hoogen, L. L., Sims, G. P., van Roon, J. A. G., & Fritsch-Stork, R. D. E. (2015) · Current Aging Science · doi:10.2174/1874609808666150727111904 · Cited by 44
Rapamycin and Dietary Restriction Induce Metabolically Distinctive Changes in Mouse Liver
Yu, Z., Wang, R., Fok, W. C., Coles, A., Salmon, A. B., & Pérez, V. (2014) · The Journals of Gerontology Series A · doi:10.1093/gerona/glu053 · Cited by 43
Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease
Galvan, V., & Hart, M. J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.11.010 · Cited by 40
Spermidine Promotes Cardioprotective Autophagy
Tong, D., & Hill, J. A. (2017) · Circulation Research · doi:10.1161/circresaha.117.310603 · Cited by 41
Teng, L.-L., Lu, G., Chiou, L., Lin, W., Cheng, Y., Hsueh, T.-E., Huang, Y.-C., Hwang, N.-H., Yeh, J.-W., Liao, R., et al. (2019) · PLoS Biology · doi:10.1371/journal.pbio.2007097 · Cited by 44
In search of antiaging modalities: Evaluation of mTOR‐ and ROS/DNA damage‐signaling by cytometry
Darżynkiewicz, Z., Zhao, H., Halicka, H. D., Li, J., Lee, Y., Hsieh, T., & WU, J. M. (2014) · Cytometry Part A · doi:10.1002/cyto.a.22452 · Cited by 41
Yamada, K., Takizawa, S., Ohgaku, Y., Asami, T., Furuya, K., Yamamoto, K., Takahashi, F., Hamajima, C., Inaba, C., Endo, K., et al. (2019) · Gene · doi:10.1016/j.gene.2019.144191 · Cited by 40
Targeting the Mitochondria-Proteostasis Axis to Delay Aging
Zimmermann, A., Madreiter-Sokolowski, C., Stryeck, S., & Abdellatif, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.656201 · Cited by 38
Anti-aging: senolytics or gerostatics (unconventional view)
Blagosklonny, M. V. (2021) · Oncotarget · doi:10.18632/oncotarget.28049 · Cited by 40
p53 and rapamycin are additive
Christy, B., Demaria, M., Campisi, J., Huang, J., Jones, D., Dodds, S. G., Williams, C., Hubbard, G., Livi, C. B., Gao, X., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4602 · Cited by 37
Solsona, R., Pavlin, L., Bernardi, H., & Sanchez, A. M. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052741 · Cited by 43
Weiss, R., Fernandez, E., Liu, Y., Strong, R., & Salmon, A. B. (2018) · Aging · doi:10.18632/aging.101401 · Cited by 36
Ham, A. S., Chojnowska, K., Tintignac, L. A. J., Lin, S., Schmidt, A., Ham, D. J., Sinnreich, M., & Rüegg, M. A. (2019) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12505 · Cited by 41
Anti-Aging Drugs and the Related Signal Pathways
Du, N., Ruigang, Y., Jiang, S., Niu, Z., Zhou, W., Liu, C., Gao, L., & Sun, Q. (2024) · Biomedicines · doi:10.3390/biomedicines12010127 · Cited by 43
Preserving Youth: Does Rapamycin Deliver?
Johnson, S. C., Martin, G. M., Rabinovitch, P. S., & Kaeberlein, M. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007316 · Cited by 35
Temsirolimus Partially Rescues the Hutchinson-Gilford Progeria Cellular Phenotype
Gabriel, D., Gordon, L. B., & Djabali, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168988 · Cited by 37
The role of DNA ‐ PK in aging and energy metabolism
Chung, J. H. (2018) · FEBS Journal · doi:10.1111/febs.14410 · Cited by 37
Validation of a geropathology grading system for aging mouse studies
Snyder, J. M., Snider, T. A., Ciol, M. A., Wilkinson, J. E., Imai, D. M., Casey, K. M., Vilches-Moure, J. G., Pettan-Brewer, C., Pillai, S. P. S., Carrasco, S. E., et al. (2019) · GeroScience · doi:10.1007/s11357-019-00088-w · Cited by 36
Aging – What it is and how to measure it
Keshavarz, M., Xie, K., Bano, D., & Ehninger, D. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111837 · Cited by 45
Self-citationLongevity pathways and memory aging
Gkikas, I., Petratou, D., & Tavernarakis, N. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00155 · Cited by 39
Hutchinson-Gilford progeria syndrome: Rejuvenating old drugs to fight accelerated ageing
Guilbert, S. M., Cardoso, D., Lévy, N., Muchir, A., & Nissan, X. (2020) · Methods · doi:10.1016/j.ymeth.2020.04.005 · Cited by 32
den Hartigh, L. J., Goodspeed, L., Wang, S. A., Kenerson, H. L., Omer, M., O’Brien, K. D., Ladiges, W., Yeung, R. S. W., & Subramanian, S. (2018) · Experimental Physiology · doi:10.1113/ep087207 · Cited by 34
Vedova, L. D., Baron, G., Morazzoni, P., Aldini, G., & Gado, F. (2025) · Pharmaceuticals · doi:10.3390/ph18020138 · Cited by 43
Rapamycin, anti-aging, and avoiding the fate of Tithonus
Richardson, A. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70800 · Cited by 32
Swindell, W. R. (2016) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw153 · Cited by 37
Mechanistic Target of Rapamycin (mTOR) Inhibitors
Wang, D., & Eisen, H. J. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_553 · Cited by 41
Effect of Chronic Administration of Low Dose Rapamycin on Development and Immunity in Young Rats
Lu, Z.-Y., Liu, F.-R., Chen, L.-L., Zhang, H.-D., Ding, Y.-M., Liu, J.-X., Wong, M., & Zeng, L.-H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135256 · Cited by 27
INFRAFRONTIER: a European resource for studying the functional basis of human disease
Raess, M., de Castro, A. A., Gailus‐Durner, V., Fessele, S., & de Angelis, M. H. (2016) · Mammalian Genome · doi:10.1007/s00335-016-9642-y · Cited by 33
Self-citationHerrera, J. J., Louzon, S., Pifer, K., Leander, D. C., Merrihew, G. E., Park, J. H., Szczesniak, K., Whitson, J. D., Wilkinson, J. E., Fiehn, O., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.137474 · Cited by 34
Emerging candidate treatment strategies for Hutchinson-Gilford progeria syndrome
Strandgren, C., Revêchon, G., Sola-Carvajal, A., & Eriksson, M. (2017) · Biochemical Society Transactions · doi:10.1042/bst20170141 · Cited by 34
de Verges, J. E., & Nehring, V. (2016) · Current Opinion in Insect Science · doi:10.1016/j.cois.2016.05.003 · Cited by 30
Lelegren, M., Liu, Y., Ross, C., Tardif, S., & Salmon, A. B. (2016) · Pathobiology of Aging & Age-related Diseases · doi:10.3402/pba.v6.31793 · Cited by 30
Reduced expression of C/EBPβ-LIP extends health and lifespan in mice
Müller, C., Zidek, L. M., Ackermann, T., de Jong, T. V., Liu, P., Kliche, V., Zaini, M. A., Kortman, G., Harkema, L., Verbeek, D. S., et al. (2018) · eLife · doi:10.7554/elife.34985 · Cited by 36
Goldberg, E. L., Smithey, M. J., Lutes, L. K., Uhrlaub, J. L., & Nikolich-Žugich, J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400188 · Cited by 29
Krześniak, M., Zajkowicz, A., Matuszczyk, I., & Rusin, M. (2014) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2014.06.002 · Cited by 31
Biotechnological Applications Derived from Microorganisms of the Atacama Desert
Azúa-Bustos, A., & González‐Silva, C. (2014) · BioMed Research International · doi:10.1155/2014/909312 · Cited by 33
Bitzer, M., & Wiggins, J. E. (2015) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2015.11.005 · Cited by 33
Endothelial mTOR maintains hematopoiesis during aging
Ramalingam, P., Poulos, M. G., Gutkin, M. C., Katsnelson, L., Freire, A. G., Lazzari, E., & Butler, J. M. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191212 · Cited by 27
Mathematical Modelling of Metabolic Regulation in Aging
Auley, M. T. M., Mooney, K., Angell, P. J., & Wilkinson, S. J. (2015) · Metabolites · doi:10.3390/metabo5020232 · Cited by 31
Geroscience approaches to increase healthspan and slow aging
Melov, S. (2016) · F1000Research · doi:10.12688/f1000research.7583.1 · Cited by 29
Xue, Q., Yang, H., Li, H.-F., Abadir, P. M., Burks, T. N., Koch, L. G., Britton, S. L., Carlson, J., Chen, L., Walston, J. D., et al. (2016) · Aging · doi:10.18632/aging.100929 · Cited by 32
Cardiac Hegemony of Senescence
Siddiqi, S., & Sussman, M. A. (2013) · Current Translational Geriatrics and Experimental Gerontology Reports · doi:10.1007/s13670-013-0064-3 · Cited by 26
Comparison of rapamycin schedules in mice on high-fat diet
Leontieva, O. V., Paszkiewicz, G., & Blagosklonny, M. V. (2014) · Cell Cycle · doi:10.4161/15384101.2014.970491 · Cited by 27
Metadata
- Authors
- Neff, F., Flores-Dominguez, D., Ryan, D. P., Horsch, M., Schröder, S., Adler, T., Afonso, L. C., Aguilar-Pimentel, J. A., Becker, L., Garrett, L., Hans, W., Hettich, M. M., Holtmeier, R., Hölter, S. M., Moreth, K., Prehn, C., Puk, O., Rácz, I., Rathkolb, B., Rozman, J., Naton, B., Ordemann, R., Adamski, J., Beckers, J., Bekeredjian, R., Busch, D. H., Ehninger, G., Graw, J., Höfler, H., Klingenspor, M., Klopstock, T., Ollert, M., Stypmann, J., Wolf, E., Wurst, W., Zimmer, A., Fuchs, H., Gailus-Durner, V., Hrabe de Angelis, M., & Ehninger, D.
- Affiliations
- Helmholtz Munich (DE)
- German Center for Neurodegenerative Diseases (DE)
- University Hospital Münster (DE)
- University of Bonn (DE)
- University Hospital Carl Gustav Carus (DE)
- Heidelberg University (DE)
- Technical University of Munich (DE)
- Ludwig-Maximilians-Universität München (DE)
- Max Planck Society (DE)
- Corresponding author
- Ehninger, Dan
- ORCID
- Ryan, Devon P.
- Adler, Thure
- Becker, Lore
- Garrett, Lillian
- Hans, Wolfgang
- Hettich, Moritz M.
- Hölter, Sabine M.
- Moreth, Kristin
- Prehn, Cornelia
- Puk, Oliver
- Rácz, Ildikó
- Rathkolb, Birgit
- Rozman, Jan
- Adamski, Jerzy
- Beckers, Johannes
- Bekeredjian, Raffi
- Busch, Dirk H.
- Ehninger, Gerhard
- Graw, Jochen
- Klingenspor, Martin
- Klopstock, Thomas
- Ollert, Markus
- Wolf, Eckhard
- Wurst, Wolfgang
- Zimmer, Andreas
- Fuchs, Helmut
- Ehninger, Dan
- Venue
- Journal of Clinical Investigation
- Published
- 2013-07-25
- Volume
- 123
- Issue
- 8
- Pages
- 3272-3291
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3726163
- OpenAlex
- W2025133084
- Cited by
- 374
- References
- 58
- Citations by year
- 2026: 13 · 2025: 23 · 2024: 16 · 2023: 22 · 2022: 17 · 2021: 32 · 2020: 19 · 2019: 24 · 2018: 28 · 2017: 20 · 2016: 41 · 2015: 58 · 2014: 48 · 2013: 13
- FWCI
- 18.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion, other-oa)
- Site cant be reached (submittedVersion)
- DZNE Pub (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- rapamycin, lifespan extension, aging, mTOR inhibition, age-related phenotypes, longevity, C57BL/6J mice
- MeSH terms
- Aging, Animals, Cell Transformation, Neoplastic, Drug Evaluation, Preclinical, Granuloma, Immunoglobulins, Leukocyte Count, Liver, Liver Cirrhosis, Longevity, Male, Mice, Inbred C57BL, Oxygen Consumption, Phenotype, Platelet Count, Psychomotor Performance, T-Lymphocytes, Thyroid Gland, Survival Analysis, Maze Learning, Sirolimus, Mice, Muscle Strength, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.